Bol Partner

Peptides and Non of Oncology Neuroendocrine Relevance

Name: Peptides and Non of Oncology Neuroendocrine Relevance
SKU: 56b7909484b620785d966ad389c69bc7
Price: 25.11 EUR
Availability: InStock

1/1

Afbeelding van Peptides and Non of Oncology Neuroendocrine Relevance

Bol Partner

Prijzen vanaf

25,11

Uitgelicht

	25,11	Naar shop
VERGELIJK ALLE AANBIEDERS (1)

Beschrijving

Bol Partner Describes the ability of a series of endocrine-derived compounds, such as CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.

Lees meer

Vergelijk aanbieders (1)

Sorteren op:

gebruikt € 25,11 Gratis verzending

Beschrijving (1)

Describes the ability of a series of endocrine-derived compounds, such as CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.

Lees meer